Mp689 * efficacy and safety of low dose versus high dose valganciclovir for prevention of cytomegalovirus disease in intermediate risk kidney transplant recipients
Source: Nephrology Dialysis Transplantation - Category: Urology & Nephrology Authors: Abdel Halim, M., Al-Otaibi, T., Gheith, O., Adel, H., Mosaad, A., Abu-Atteya, H., Zakaria, Z., Makkeya, Y., Said, T., Nair, P., Nampoory, M. Tags: RENAL TRANSPLANTATION. CLINICAL - 2 Source Type: research
More News: Cytomegalovirus | Dialysis | Kidney Transplant | Kidney Transplantation | Transplant Surgery | Transplants | Urology & Nephrology